Literature DB >> 32165854

Coronavirus disease-2019: is fever an adequate screening for the returning travelers?

George M Bwire1, Linda S Paulo2.   

Abstract

On Thursday, 30 January 2020, World Health Organization declared Coronavirus disease-2019 (COVID-2019) a Public Health Emergency of International Concern. Since its identification in late December 2019 in Wuhan, Hubei Province, People's Republic of China, the number of cases imported into other countries is increasing, and the epidemiological map is changing rapidly. On the other hand, body temperature screening (fever) is the major test performed at points of entry, i.e., airports, in the returning travelers in most of the countries with limited resources. However, the recent report on asymptomatic contact transmission of COVID-19 and travelers who passed the symptoms-based screening and tested positive for COVID-19 using reverse transcription polymerase chain reaction (RT-PCR) challenges this approach as body temperature screening may miss travelers incubating the disease or travelers concealing fever during travel. On this note, travel restrictions to and from high risk areas and/or 14 days quarantine of travelers coming from high risk areas are recommended to prevent possible importation of COVID-19. Currently, RT-PCR is a reliable test in detecting both symptomatic and asymptomatic COVID-19.
© The Author(s) 2020.

Entities:  

Keywords:  COVID-19; Fever; Returning travelers; Temperature screening

Year:  2020        PMID: 32165854      PMCID: PMC7061485          DOI: 10.1186/s41182-020-00201-2

Source DB:  PubMed          Journal:  Trop Med Health        ISSN: 1348-8945


To the Editor, Since the outbreak of Coronavirus on December 31, 2019 in Wuhan, Hubei Province, People’s Republic of China, the number of cases from China that have been imported into other countries is increasing, and the epidemiological map is changing rapidly [1]. In this regard, World Health Organization (WHO) on Thursday, 30 January 2020, announced a Coronavirus disease-2019 (COVID-19) a Public Health Emergency of International Concern (PHEIC). To curb the spread of COVID-19, WHO has implemented several public health measures including rapid identification, diagnosis and management of the cases, identification and follow-up of contacts, infection prevention and control in health care settings, implementation of health measures for travelers, awareness rising in the population, and risk communication [2]. Additionally, countries are taking measures to prevent the importation of COVID-19, i.e., on January 31, 2020, the President of the USA signed a presidential “Proclamation on Suspension of Entry as Immigrants and Non-immigrants of Persons who Pose a Risk of Transmitting COVID-19” [3]. Other measures implemented elsewhere include quarantine of travelers coming from risk countries and symptoms-based screening at points of entry [4], which were also employed during Ebola outbreaks. In support of this approach, WHO reported that temperature screening at entry detected the majority of exported cases during the current outbreak with the COVID-19 [5]. However, 4 people in Germany were infected with Coronavirus-2019 through contact with an asymptomatic patient [6], although there is a claim that the patient from China who transmitted the virus when she/he was attending the business meeting in Germany was symptomatic [7]. But, evidence is still clear that the other 2 patients who never came into contact with the Chinese patient contracted the virus from an asymptomatic German patient who attended the meeting with a Chinese patient. This added to the ongoing debates about virus transmission, where some of the scientists believe that asymptomatic patients are transmitting the infection. WHO says “People who cough or sneeze are more likely to spread the virus,…But even if they do, asymptomatic transmission likely plays a minor role in the epidemic overall.” Additionally, evidence from Germany reported that 2 out of 114 travelers (1.8%) from Wuhan, China, who had passed the symptoms-based screening tested positive for COVID-19 by reverse transcription polymerase chain reaction (RT-PCR) [8]. More interestingly, Japanese citizens evacuated from the source of a COVID-19 outbreak that have been diagnosed with the infection after initially testing negative, a man in his 50s who returned from the Chinese city of Wuhan on the first Japanese evacuation flight on January 29, 2020, previously twice tested negative for the virus. However, a third test 12 days later found the man—who has been isolated in his hotel room since his return was infected. In addition to that, the number of people in Diamond Princess testing positive for COVID-19 keep on increasing, since it arrived off Japan [9]. A case from the UK reports on the British businessman who is linked to 11 coronavirus cases that a suspect was advised to attend an isolated room at hospital, despite showing no symptoms and later tested positive for COVID-19 [10]. National Health Service has advised any individual experiencing symptoms, even if mild, after traveling from mainland China, Thailand, Japan, Republic of Korea, Hong Kong, Taiwan, Singapore, Malaysia, or Macau, to stay indoors. In Africa, Egypt is the first country to confirm COVID-19 infection and the country’s health ministry says the affected person is a non-Egypt citizen (foreigner) who presented with no serious symptoms [11]. The second COVID-19 case in Africa has been reported to occur in Algeria from a foreigner coming from the northern part of Italy who arrived in the country on Feb 17, 2020. Northern Italy, home to many Algerians, has been the center of an outbreak of the coronavirus with more than 280 cases and 11 deaths [12]. From Latin America, Brazil is the first country to confirm the case of COVID-19 in a 61-year-old who had visited Italy [13]. Lastly, a published study on clinical characteristics of 138 hospitalized patients with COVID-19 in Wuhan, China, documented that fever was present in 98.6% (136/138) of hospitalized patients, whereas 2 non-intensive care unit patients (1.4%) did not present with fever [14]. In this regard, body temperature might not be an adequate screening as it can potentially miss travelers incubating the disease or travelers concealing fever during travel and contribute to the importation of the virus to the countries of destination. Therefore, travel restrictions to and from high risk areas [1] and/or 14-day quarantine [15] of people coming from high risk areas are recommended to prevent possible importation of COVID-19. Currently, RT-PCR is a reliable test in detecting both symptomatic and asymptomatic COVID-19 [6, 8]. Lastly, in previous experience from other viral outbreaks, i.e., dengue virus [16] and Ebola [17], fever screening especially at airport had a positive effect on partially blocking importation of cases. Kuan et al. [16] reported that airport fever screening was successful in identifying 45% (244/542; 95% confidence interval 33.1–57.8%) of imported dengue cases with fever.
  5 in total

Review 1.  Approach to Fever in the Returning Traveler.

Authors:  Guy E Thwaites; Nicholas P J Day
Journal:  N Engl J Med       Date:  2017-02-09       Impact factor: 91.245

2.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

3.  Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.

Authors:  Camilla Rothe; Mirjam Schunk; Peter Sothmann; Gisela Bretzel; Guenter Froeschl; Claudia Wallrauch; Thorbjörn Zimmer; Verena Thiel; Christian Janke; Wolfgang Guggemos; Michael Seilmaier; Christian Drosten; Patrick Vollmar; Katrin Zwirglmaier; Sabine Zange; Roman Wölfel; Michael Hoelscher
Journal:  N Engl J Med       Date:  2020-01-30       Impact factor: 91.245

4.  Epidemiological trends and the effect of airport fever screening on prevention of domestic dengue fever outbreaks in Taiwan, 1998-2007.

Authors:  Mei-Mei Kuan; Ting Lin; Jen-Hsiang Chuang; Ho-Sheng Wu
Journal:  Int J Infect Dis       Date:  2010-06-19       Impact factor: 3.623

5.  Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China.

Authors:  Sebastian Hoehl; Holger Rabenau; Annemarie Berger; Marhild Kortenbusch; Jindrich Cinatl; Denisa Bojkova; Pia Behrens; Boris Böddinghaus; Udo Götsch; Frank Naujoks; Peter Neumann; Joscha Schork; Petra Tiarks-Jungk; Antoni Walczok; Markus Eickmann; Maria J G T Vehreschild; Gerrit Kann; Timo Wolf; René Gottschalk; Sandra Ciesek
Journal:  N Engl J Med       Date:  2020-02-18       Impact factor: 91.245

  5 in total
  26 in total

1.  Fever with Rash is One of the First Presentations of COVID-19 in Children: A Case Report.

Authors:  Mohammad Reza Navaeifar; Mehrdad Poudineh Ghazaghi; Leila Shahbaznejad; Hamed Rouhanizadeh; Mahnush Abutalebi; Mobina Ranjbar Varandi; Mohammad Sadegh Rezai
Journal:  Int Med Case Rep J       Date:  2020-08-07

2.  Clinical Characteristics of Adult Fevered COVID-19 Patients and Predictors for Developing Severe Events.

Authors:  Guyi Wang; Quan Zhang; Chenfang Wu; Fang Wu; Bo Yu; Jianlei Lv; Siye Zhang; Guobao Wu; Yanjun Zhong
Journal:  Front Med (Lausanne)       Date:  2020-07-03

3.  A novel protective barrier enclosure for performing bronchoscopy.

Authors:  Shinichi Yamamoto; Masayuki Nakayama; Hiroyoshi Tsubochi; Shunsuke Endo
Journal:  Respir Investig       Date:  2020-09-16

4.  Real-World Evidence: The Low Validity of Temperature Screening for COVID-19 Triage.

Authors:  Bogdan C Pană; Henrique Lopes; Florentina Furtunescu; Diogo Franco; Anca Rapcea; Mihai Stanca; Alina Tănase; Anca Coliţă
Journal:  Front Public Health       Date:  2021-06-30

5.  Impact of international travel dynamics on domestic spread of 2019-nCoV in India: origin-based risk assessment in importation of infected travelers.

Authors:  Sachin S Gunthe; Satya S Patra
Journal:  Global Health       Date:  2020-05-12       Impact factor: 4.185

6.  Temperature screening has negligible value for control of COVID-19.

Authors:  Biswadev Mitra; Carl Luckhoff; Rob D Mitchell; Gerard M O'Reilly; De Villiers Smit; Peter A Cameron
Journal:  Emerg Med Australas       Date:  2020-08-17       Impact factor: 2.279

7.  Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now?

Authors:  Carlo Torti; Maria Mazzitelli; Enrico Maria Trecarichi; Owachi Darius
Journal:  BMC Infect Dis       Date:  2020-06-15       Impact factor: 3.090

8.  The COVID-19 response must integrate people living with HIV needs in Sub-Saharan Africa: the case of Mali.

Authors:  Luis Sagaon-Teyssier; Adam Yattassaye; Michel Bourrelly; Bintou Dembélé Keïta; Bruno Spire
Journal:  Trop Med Health       Date:  2020-06-03

9.  Updating the diagnostic criteria of COVID-19 "suspected case" and "confirmed case" is necessary.

Authors:  Yun-Yun Wang; Ying-Hui Jin; Xue-Qun Ren; Yi-Rong Li; Xiao-Chun Zhang; Xian-Tao Zeng; Xing-Huan Wang
Journal:  Mil Med Res       Date:  2020-04-04

Review 10.  Diagnosing COVID-19 in the Emergency Department: A Scoping Review of Clinical Examinations, Laboratory Tests, Imaging Accuracy, and Biases.

Authors:  Christopher R Carpenter; Philip A Mudd; Colin P West; Erin Wilber; Scott T Wilber
Journal:  Acad Emerg Med       Date:  2020-07-26       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.